학술논문
PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Study
Document Type
Abstract
Author
Source
In Value in Health June 2021 24 Supplement 1:S19-S19
Subject
Language
ISSN
1098-3015